Category: Cambridge Massachusetts

Startup focused on B-cell therapies launched with $52M in Series A

Posted on October 25, 2020 by Nile

Massachusetts-based Be Biopharma will use the proceeds to build a team as it seeks to develop B-cell therapies for a variety of diseases.

Glympse Bio raises more than $46M in Series B round for biosensor technology

Posted on July 15, 2020 by Nile

The company is developing biosensors, initially for NASH, that could be used in place of liver biopsy and have applicability in development of drugs for the disease.